These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6787978)

  • 1. In vitro comparison of dibekacin and gentamicin activities.
    Hill CD; Counts GW; Turck M
    Antimicrob Agents Chemother; 1981 Jan; 19(1):190-2. PubMed ID: 6787978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.
    Paradelis AG; Douboyas J; Stathopoulos G; Grigoriadou-Edipides A; Triantaphylidis C; Papapanagiotou J
    Antimicrob Agents Chemother; 1978 Sep; 14(3):514-5. PubMed ID: 101135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
    Tsuchiya K; Kondo M
    Antimicrob Agents Chemother; 1978 Mar; 13(3):536-9. PubMed ID: 122528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
    Kobayashi F; Saino Y; Koshi T; Hattori Y
    Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibacterial activity of dibekacin against gentamicin-resistant organisms.
    Hamada M; Homma Y; Tamamura T; Kondo S
    Jpn J Antibiot; 1977 Feb; 30(2):203-5. PubMed ID: 853578
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
    G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the in vitro activity of dibekacin, piperacillin, cefotaxime and cefuroxime on gram-negative bacteria].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M
    G Batteriol Virol Immunol; 1983; 76(7-12):239-45. PubMed ID: 6099296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin: synergism with aminoglycosides in vitro.
    Une T; Osada Y; Ogawa H
    Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation in vitro synergism on ampicillin with cloxacillin and dibekacin against glucose non-fermenting gram-negative bacilli and Serratia (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1978 Oct; 31(10):610-3. PubMed ID: 366194
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.
    Pulliam L; Hadley WK; Mills J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):490-2. PubMed ID: 6454384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.